CureVac N.V (NASDAQ:CVAC) price on Thursday, July 03, rose 0.93% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $5.45.
A look at the stock’s price movement, the close in the last trading session was $5.4, moving within a range at $5.38 and $5.45. The beta value (5-Year monthly) was 2.491 while the PE ratio in trailing twelve months stood at 6.05. Turning to its 52-week performance, $5.72 and $2.37 were the 52-week high and 52-week low respectively. Overall, CVAC moved 15.96% over the past month.
CureVac N.V’s market cap currently stands at around $1.23 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-May-20.
The average forecast suggests down to a -76.88% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 69.05M, representing a -87.10% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that CVAC is a 100% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
2 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 2 recommend CVAC as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
CVAC’s current price about 5.34% and 25.29% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 65.91, while 7-day volatility ratio is 1.30% and 2.90% in the 30-day chart. Further, CureVac N.V (CVAC) has a beta value of 2.53. Analysts have given the company’s stock an average 52-week price target of $5, forecast between a low of $5 and high of $5. Looking at the price targets, the low is 8.26% off current price level while to achieve the yearly target high, price needs to move 8.26%. Nonetheless, investors will most likely welcome a 8.26% jump to $5 which is the analysts’ median price.
If we refocus on CureVac N.V (NASDAQ:CVAC), historical trading data shows that trading volumes averaged 0.96 over the past 10 days and 1.17 million over the past 3 months. The company’s latest data on shares outstanding shows there are 225.16 million shares.
The 57.58% of CureVac N.V’s shares are in the hands of company insiders while institutional holders own 3.57% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 2.6 million on 2025-06-13, giving us a short ratio of 1.37. The data shows that as of 2025-06-13 short interest in CureVac N.V (CVAC) stood at 231.0 of shares outstanding, with shares short falling to 4.89 million registered in 2025-05-15. Current price change has pushed the stock 63.66% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the CVAC stock continues to rise going into the next quarter.
